Antagonizing Nogo-receptor 1 promotes the number of cultured dopaminergic neurons and elongates their neurites

NeuroReport

Volumn 24, Issue 18, 2013, Pages 1047-1052

  Seiler, Stefanie ^a,b   Pollini, Dario ^a   Di Santo, Stefano ^a   Widmer, Hans R ^a,b  

^a Department of Neurosurgery Neurocenter and Regenerative Neuroscience Cluster ^*  (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cell numbers; Morphology; NEP1 40; Nogo A receptor; Parkinson's disease; Rat; Tissue culture; Tyrosine hydroxylase; Ventral mesencephalon

Indexed keywords

NOGO RECEPTOR 1; PROTEIN NOGO; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL COUNT; CELL DENSITY; CELL ELONGATION; CELL STRUCTURE; CENTRAL NERVOUS SYSTEM; DISSOCIATED CELL CULTURE; DOPAMINERGIC NERVE CELL; EMBRYO; IMMUNOREACTIVITY; MESENCEPHALON; NERVE FIBER GROWTH; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL COUNT; CELLS, CULTURED; DOPAMINERGIC NEURONS; FETUS; GPI-LINKED PROTEINS; MYELIN PROTEINS; NEURITES; PEPTIDE FRAGMENTS; RATS; RECEPTORS, CELL SURFACE;

EID: 84889263201     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0000000000000063     Document Type: Article

References (26)

1. Schwab ME. Nogo and axon regeneration. Curr Opin Neurobiol 2004; 14:118-124. (Pubitemid 38264581)
2. Jokic N, Gonzalez de Aguilar JL, Pradat PF, Dupuis L, Echaniz-Laguna A, Muller A, et al. Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity. Ann Neurol 2005; 57:553-556. (Pubitemid 40471166)
3. Dodd DA, Niederoest B, Bloechlinger S, Dupuis L, Loeffler JP, Schwab ME. Nogo-A, -B, and -C are found on the cell surface and interact together in many different cell types. J Biol Chem 2005; 280:12494-12502.
4. Josephson A, Trifunovski A, Widmer HR, Widenfalk J, Olson L, Spenger C. Nogo-receptor gene activity: cellular localization and developmental regulation of mRNA in mice and humans. J Comp Neurol 2002; 453:292-304. (Pubitemid 35222357)
5. Willi R, Aloy EM, Yee BK, Feldon J, Schwab ME. Behavioral characterization of mice lacking the neurite outgrowth inhibitor Nogo-A. Genes Brain Behav 2009; 8:181-192.
6. Gao Y, Xiao Z, Chen B, Wang B, Han J, Zhao Y, et al. Effect of different regions of Nogo-A on the differentiation of neural progenitors. Neurosci Lett 2009; 458:132-135.
7. Schwab JM, Tuli SK, Failli V. The Nogo receptor complex: confining molecules to molecular mechanisms. Trends Mol Med 2006; 12:293-297. (Pubitemid 44094289)
8. Atalay B, Bavbek M, Cekinmez M, Ozen O, Nacar A, Karabay G, Gulsen S. Antibodies neutralizing Nogo-A increase pan-cadherin expression and motor recovery following spinal cord injury in rats. Spinal Cord 2007; 45:780-786. (Pubitemid 350224262)
9. Craveiro LM, Hakkoum D, Weinmann O, Montani L, Stoppini L, Schwab ME. Neutralization of the membrane protein Nogo-A enhances growth and reactive sprouting in established organotypic hippocampal slice cultures. Eur J Neurosci 2008; 28:1808-1824.
10. Ourednik V, Ourednik J. Graft/host relationships in the developing and regenerating CNS of mammals. Ann N Y Acad Sci 2005; 1049:172-184. (Pubitemid 40967584)
11. Alsberg E, von Recum HA, Mahoney MJ. Environmental cues to guide stem cell fate decision for tissue engineering applications. Expert Opin Biol Ther 2006; 6:847-866.
12. Nyatia E, Lang DM. Localisation and expression of a myelin associated neurite inhibitor, Nogo-A and its receptor Nogo-receptor by mammalian CNS cells. Res Vet Sci 2007; 83:287-301. (Pubitemid 47386970)
13. Schawkat K, Di Santo S, Ducray A, Raabe A, Widmer HR. Loss of Nogo-A expressing neurons in a rat model of Parkinson's disease. Abstracts for the 11th International Neural Therapy and Repair Meeting. Cell Transplant 2011; 20:582.
14. Inoue H, Lin L, Lee X, Shao Z, Mendes S, Snodgrass-Belt P, et al. Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models. Proc Natl Acad Sci USA 2007; 104:14430-14435. (Pubitemid 350003278)
15. Meyer M, Widmer HR, Wagner B, Guzman R, Evtouchenko L, Seiler RW, Spenger C. Comparison of mesencephalic free-floating tissue culture grafts and cell suspension grafts in the 6-hydroxydopamine-lesioned rat. Exp Brain Res 1998; 119:345-355. (Pubitemid 28118742)
16. Widmer HR, Schaller B, Meyer M, Seiler RW. Glial cell line-derived neurotrophic factor stimulates the morphological differentiation of cultured ventral mesencephalic calbindin- and calretinin-expressing neurons. Exp Neurol 2000; 164:71-81. (Pubitemid 30490724)
17. Abercrombie M. Estimation of nuclear population from microtome sections. Anat Rec 1946; 94:239-247.
18. Andres RH, Ducray AD, Perez-Bouza A, Schlattner U, Huber AW, Krebs SH, et al. Creatine supplementation improves dopaminergic cell survival and protects against MPP + toxicity in an organotypic tissue culture system. Cell Transplant 2005; 14:537-550. (Pubitemid 41739258)
19. Alexi T, Borlongan CV, Faull RL, Williams CE, Clark RG, Gluckman PD, Hughes PE. Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. Prog Neurobiol 2000; 60:409-470. (Pubitemid 30058341)
20. Andres RH, Ducray AD, Schlattner U, Wallimann T, Widmer HR. Functions and effects of creatine in the central nervous system. Brain Res Bull 2008; 76:329-343.
21. Andres RH, Meyer M, Ducray AD, Widmer HR. Restorative neuroscience: concepts and perspectives. Swiss Med Wkly 2008; 138 (11-12):155-172. (Pubitemid 351480810)
22. Hoglinger GU, Widmer HR, Spenger C, Meyer M, Seiler RW, Oertel WH, Sautter J. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease. Exp Neurol 2001; 167:148-157. (Pubitemid 32066417)
23. Meyer M, Matarredona ER, Seiler RW, Zimmer J, Widmer HR. Additive effect of glial cell line-derived neurotrophic factor and neurotrophin-4/5 on rat fetal nigral explant cultures. Neuroscience 2001; 108:273-284. (Pubitemid 33152968)
24. Dupuis L, Pehar M, Cassina P, Rene F, Castellanos R, Rouaux C, et al. Nogo receptor antagonizes p75NTR-dependent motor neuron death. Proc Natl Acad Sci USA 2008; 105:740-745. (Pubitemid 351171778)
25. Cao Y, Shumsky JS, Sabol MA, Kushner RA, Strittmatter S, Hamers FP, et al. Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat. Neurorehabil Neural Repair 2008; 22:262-278. (Pubitemid 351561674)
26. Kubo T, Nonomura T, Enokido Y, Hatanaka H. Brain-derived neurotrophic factor (BDNF) can prevent apoptosis of rat cerebellar granule neurons in culture. Brain Res Dev Brain Res 1995; 85:249-258.